bsm-33071M Search Results


anti non phospho β catenin monoclonal antibody  (Bioss)
90
Bioss anti non phospho β catenin monoclonal antibody
Representative images of immunohistochemical staining of Cx26, <t>β‐catenin,</t> and Wnt3a in gastric cancer. 200‐fold magnification. A: Cx26 expression in noncancerous regions; B: low cytoplasmic Cx26 expression in cancerous regions; C: high cytoplasmic Cx26 expression in cancerous regions; D: low nuclear β‐catenin expression in cancerous regions; E: high nuclear β‐catenin expression in cancerous regions; F: low nuclear Wnt3a expression in cancerous regions; G: high Wnt3a expression in cancerous regions
Anti Non Phospho β Catenin Monoclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti non phospho β catenin monoclonal antibody/product/Bioss
Average 90 stars, based on 1 article reviews
anti non phospho β catenin monoclonal antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Representative images of immunohistochemical staining of Cx26, β‐catenin, and Wnt3a in gastric cancer. 200‐fold magnification. A: Cx26 expression in noncancerous regions; B: low cytoplasmic Cx26 expression in cancerous regions; C: high cytoplasmic Cx26 expression in cancerous regions; D: low nuclear β‐catenin expression in cancerous regions; E: high nuclear β‐catenin expression in cancerous regions; F: low nuclear Wnt3a expression in cancerous regions; G: high Wnt3a expression in cancerous regions

Journal: Annals of Gastroenterological Surgery

Article Title: Cytoplasmic localization of connexin 26 suppresses transition of β‐catenin into the nucleus in intestinal‐ and mix‐type gastric cancer

doi: 10.1002/ags3.12552

Figure Lengend Snippet: Representative images of immunohistochemical staining of Cx26, β‐catenin, and Wnt3a in gastric cancer. 200‐fold magnification. A: Cx26 expression in noncancerous regions; B: low cytoplasmic Cx26 expression in cancerous regions; C: high cytoplasmic Cx26 expression in cancerous regions; D: low nuclear β‐catenin expression in cancerous regions; E: high nuclear β‐catenin expression in cancerous regions; F: low nuclear Wnt3a expression in cancerous regions; G: high Wnt3a expression in cancerous regions

Article Snippet: Anti‐Non‐phospho β‐catenin monoclonal antibody (1:600 dilution), and the Wnt3a antibody was Wnt3a (Bioss Antibodies, MA, USA), Wnt3a Polyclonal Antibody (1:200 dilution).

Techniques: Immunohistochemical staining, Staining, Expressing

Investigation of the relationship between cytoplasmic Cx26 and β‐catenin (A,B) and PLA results for MKN7/MKN45. Red dots represent the binding of Cx26 to β‐catenin. (C) Co‐immunoprecipitation results for MKN7/MKN45/MKN74

Journal: Annals of Gastroenterological Surgery

Article Title: Cytoplasmic localization of connexin 26 suppresses transition of β‐catenin into the nucleus in intestinal‐ and mix‐type gastric cancer

doi: 10.1002/ags3.12552

Figure Lengend Snippet: Investigation of the relationship between cytoplasmic Cx26 and β‐catenin (A,B) and PLA results for MKN7/MKN45. Red dots represent the binding of Cx26 to β‐catenin. (C) Co‐immunoprecipitation results for MKN7/MKN45/MKN74

Article Snippet: Anti‐Non‐phospho β‐catenin monoclonal antibody (1:600 dilution), and the Wnt3a antibody was Wnt3a (Bioss Antibodies, MA, USA), Wnt3a Polyclonal Antibody (1:200 dilution).

Techniques: Binding Assay, Immunoprecipitation

Changes in cell proliferation capacity upon forced expression of Cx26. (A) MKN7 (B) MKN74, cytoplasmic Cx26, and nuclear β‐catenin expressions examined by western blotting. (A) MKN7 (B) MKN74

Journal: Annals of Gastroenterological Surgery

Article Title: Cytoplasmic localization of connexin 26 suppresses transition of β‐catenin into the nucleus in intestinal‐ and mix‐type gastric cancer

doi: 10.1002/ags3.12552

Figure Lengend Snippet: Changes in cell proliferation capacity upon forced expression of Cx26. (A) MKN7 (B) MKN74, cytoplasmic Cx26, and nuclear β‐catenin expressions examined by western blotting. (A) MKN7 (B) MKN74

Article Snippet: Anti‐Non‐phospho β‐catenin monoclonal antibody (1:600 dilution), and the Wnt3a antibody was Wnt3a (Bioss Antibodies, MA, USA), Wnt3a Polyclonal Antibody (1:200 dilution).

Techniques: Expressing, Western Blot

Cage analysis: changes in downstream genes and signaling pathways when expression of Cx26 is forced in the MKN74 cell line (A) Enrichment analysis. Changes in Wnt/β‐catenin downstream genes (B) KEGG pathway analysis focusing on the Wnt/β‐catenin pathway. *Reduced expression when Cx26 is highly expressed

Journal: Annals of Gastroenterological Surgery

Article Title: Cytoplasmic localization of connexin 26 suppresses transition of β‐catenin into the nucleus in intestinal‐ and mix‐type gastric cancer

doi: 10.1002/ags3.12552

Figure Lengend Snippet: Cage analysis: changes in downstream genes and signaling pathways when expression of Cx26 is forced in the MKN74 cell line (A) Enrichment analysis. Changes in Wnt/β‐catenin downstream genes (B) KEGG pathway analysis focusing on the Wnt/β‐catenin pathway. *Reduced expression when Cx26 is highly expressed

Article Snippet: Anti‐Non‐phospho β‐catenin monoclonal antibody (1:600 dilution), and the Wnt3a antibody was Wnt3a (Bioss Antibodies, MA, USA), Wnt3a Polyclonal Antibody (1:200 dilution).

Techniques: Expressing